Verve Therapeutics shares owned by TD Asset Management
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by TD Asset Management
from 13F filings
Historical chart of TD Asset Management investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Verve Therapeutics by TD Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $656k | 47k | 13.94 |
2023-09-30 | $412k | 31k | 13.26 |
2023-06-30 | $582k | 31k | 18.75 |
2023-03-31 | $448k | 31k | 14.42 |
2022-12-31 | $481k | 25k | 19.35 |
2022-09-30 | $463k | 14k | 34.19 |